Cargando…
Investigation on the use of fused deposition modeling for the production of IR dosage forms containing Timapiprant
The present work focused on evaluating the feasibility of fused deposition modeling (FDM) in the development of a dosage form containing Timapiprant (TMP), also known as CHF6532, which is a novel active molecule indicated in the potential treatment of eosinophilic asthma upon oral administration. Th...
Autores principales: | Uboldi, Marco, Chiappa, Arianna, Pertile, Marisa, Piazza, Alessandro, Tagliabue, Stefano, Foppoli, Anastasia, Palugan, Luca, Gazzaniga, Andrea, Zema, Lucia, Melocchi, Alice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823139/ https://www.ncbi.nlm.nih.gov/pubmed/36624741 http://dx.doi.org/10.1016/j.ijpx.2022.100152 |
Ejemplares similares
-
Drop-on-powder 3D printing of amorphous high dose oral dosage forms: Process development, opportunities and printing limitations
por: Gottschalk, Nadine, et al.
Publicado: (2022) -
Inkjet drug printing onto contact lenses: Deposition optimisation and non-invasive dose verification
por: Pollard, Thomas D., et al.
Publicado: (2022) -
The Chronotopic™ System for Pulsatile and Colonic Delivery of Active Molecules in the Era of Precision Medicine: Feasibility by 3D Printing via Fused Deposition Modeling (FDM)
por: Melocchi, Alice, et al.
Publicado: (2021) -
3D printed matrix solid forms: Can the drug solubility and dose customisation affect their controlled release behaviour?
por: dos Santos, Juliana, et al.
Publicado: (2022) -
Additive manufacturing technologies with emphasis on stereolithography 3D printing in pharmaceutical and medical applications: A review
por: Lakkala, Preethi, et al.
Publicado: (2023)